Advertisement

Subscribe
Newsletter Signup

Issues
News
- 2025
- 2024
- 2023
- 2022
Diseases & Conditions
Topics
Departments
Multimedia
Conferences
Resources

Subscribe

Publication to search:

PentaVision

Publications

Optometric Management

Issues
News
- 2025
- 2024
- 2023
- 2022
Diseases & Conditions
Topics
Departments
Multimedia
Conferences
Resources

https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://optometricmanagement.com/media/1kppm0aa/may-cover.jpg

Contact Lens Spectrum

Contact Lens Spectrum

https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://optometricmanagement.com/media/sryf2sm3/_eb0525_higher_res_web_veronica.jpg

Eyecare Business

Eyecare Business

https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://optometricmanagement.com/media/lpsdko3d/cover.jpg

Optometric Management

Optometric Management

The Complete Bausch + Lomb ULTRA® Product Family

Provide your patients all-day comfort and consistently clear vision¹

REFERENCE:
1. Based on patient surveys after wearing Bausch + Lomb ULTRA^®, Bausch + Lomb ULTRA^® for Presbyopia, or Bausch + Lomb ULTRA^® contact lenses for Astigmatism for at least 5 days.

Bausch + Lomb ULTRA is a trademark of Bausch & Lomb Incorporated or its affiliates.
ZUS.0210.USA.17

Advertisement

Recommendations

Advertisement

Explore

About Us
Archive
Article Feedback
Contact Us

Resources

Submission Guidelines
Social Media Community Guidelines
Magazine Subscription
Article Reprints
Professional Associations

Follow Us

Facebook
X (Twitter)
Instagram
LinkedIn

Visit Conexiant's Other Ophthalmology and Optometry Publications

Copyright © 2025 Conexiant unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.